Oncology PracticeTo stay: Two more cancer indications with ‘dangling approvals’April 29, 2021Genitourinary CancerImmunotherapy
Oncology PracticeFDA panel backs atezolizumab for mTNBC – at least for nowApril 28, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeFDA approves new immunotherapy for endometrial cancerApril 23, 2021Gynecologic Cancer
Oncology PracticeFDA approves frontline immunotherapy for gastric cancersApril 16, 2021Gastrointestinal CancerGI Oncology
Hematology NewsCDC panel: Pause of J&J COVID-19 vaccine to remain for nowApril 15, 2021COVID-19 Updates
Oncology PracticeFDA approves first AI device to detect colon lesionsApril 12, 2021Gastrointestinal CancerGastroenterology
Hematology NewsList of COVID-19 high-risk comorbidities expandedApril 6, 2021COVID-19 UpdatesLung Cancer
Hematology NewsCDC adds new medical conditions to COVID-19 high-risk listMarch 31, 2021COVID-19 Updates
Oncology PracticeFDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareBreast CancerGastrointestinal CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsCDC data strengthen link between obesity and severe COVIDMarch 9, 2021COVID-19 Updates
Hematology NewsFDA authorizes first molecular at-home, OTC COVID-19 testMarch 9, 2021COVID-19 Updates
